• SENSEX
    NIFTY 50
Healthcare

US FDA declines approval of Novartis' cholesterol-lowering drug

Updated : December 19, 2020 07:52 PM IST

US health regulator declined to approve inclisiran, the Swiss drugmaker’s potential treatment for elevated low-density cholesterol in adults
No onsite inspection was conducted by the FDA, the company said.
US FDA declines approval of Novartis' cholesterol-lowering drug

You May Also Like

Live TV

recommended for you

Advertisement